Patent details
EP2224925 Title: COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
Basic Information
- Publication number:
- EP2224925
- PCT Application Number:
- PCT/SE/2008/051450
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP088633243
- PCT Publication Number:
- WO/2009/078794
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
- French Title of Invention:
- COMPOSÉS DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DU CANCER
- German Title of Invention:
- VERBINDUNGEN ZUR KREBSBEHANDLUNG
- SPC Number:
Dates
- Filing date:
- 12/12/2008
- Grant date:
- 09/09/2015
- EP Publication Date:
- 09/09/2015
- PCT Publication Date:
- 25/06/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/09/2010
- EP B1 Publication Date:
- 09/09/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 12/12/2015
- Expiration date:
- 12/12/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/12/2008
- Name:
- Pledpharma AB
- Address:
- Grev Turegatan 7, 114 46 Stockholm, Sweden (SE)
Inventor
1
- Name:
- KURZ Tino
- Address:
- Sweden (SE)
2
- Name:
- ANDERSSON Rolf
- Address:
- Sweden (SE)
3
- Name:
- KARLSSON Jan Olof G.
- Address:
- Norway (NO)
Priority
- Priority Number:
- 6010
- Priority Date:
- 28/12/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/44;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|